Evidence map›Paper›PMID 35256668›Full record

ArticleScientific reports2022

Link between the EZH2 noncanonical pathway and microtubule organization center polarization during early T lymphopoiesis.

Frederique Deshayes, Magali Fradet, Sandra Kaminski, Mireille Viguier, Jean-Pol Frippiat, Stephanie Ghislin

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Frederique DeshayesUniversité de Paris, CNRS, Unité de Biologie Fonctionnelle et Adaptative, Paris, France.
Magali FradetUniversité de Paris, CNRS, Institut Jacques Monod, 75006, Paris, France.
Sandra KaminskiEA 7300, Stress Immunity Pathogens Laboratory, Faculty of Medicine, Lorraine University, 9 avenue de la forêt de Haye, 54500, Vandœuvre-lès-Nancy, France.
Mireille ViguierUniversité de Paris, CNRS, Unité de Biologie Fonctionnelle et Adaptative, Paris, France.
Jean-Pol FrippiatEA 7300, Stress Immunity Pathogens Laboratory, Faculty of Medicine, Lorraine University, 9 avenue de la forêt de Haye, 54500, Vandœuvre-lès-Nancy, France. jean-pol.frippiat@univ-lorraine.fr.
Stephanie GhislinEA 7300, Stress Immunity Pathogens Laboratory, Faculty of Medicine, Lorraine University, 9 avenue de la forêt de Haye, 54500, Vandœuvre-lès-Nancy, France. stephanie.ghislin@univ-lorraine.fr.
Centre National de la Recherche Scientifique · FRStress, immunité, pathogènes

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

EZH2 plays an essential role at the β-selection checkpoint of T lymphopoiesis by regulating histone H3 lysine 27 trimethylation (H3K27me3) via its canonical mode of action. Increasing data suggest that EZH2 could also regulate other cellular functions, such as cytoskeletal reorganization, via its noncanonical pathway. Consequently, we investigated whether the EZH2 noncanonical pathway could be involved in early T-cell maturation, which requires cell polarization. We observed that EZH2 localization is tightly regulated during the early stages of T-cell development and that EZH2 relocalizes in the nucleus of double-negative thymocytes enduring TCRβ recombination and β-selection processes. Furthermore, we observed that EZH2 and EED, but not Suz12, colocalize with the microtubule organization center (MTOC), which might prevent its inappropriate polarization in double negative cells. In accordance with these results, we evidenced the existence of direct or indirect interaction between EED and α-tubulin. Taken together, these results suggest that the EZH2 noncanonical pathway, in association with EED, is involved in the early stages of T-cell maturation.

Indexed as

LymphopoiesisThymocytesCell DifferentiationCell NucleusEnhancer of Zeste Homolog 2 ProteinMicrotubulesEnhancer of Zeste Homolog 2 Protein

Identifiers

PMID35256668
PMCPMC8901749
OpenAlexW4220933283

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.